Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial

导出原文传递

翻译打印收藏纠错

作者： Liang, Jin-Hua ^[1] ; Wang, Li ^[2] ; Zhu, Hua-Yuan ^[3] ; Qian, Jun ; Liao, Hui ; Wu, Jia-Zhu ; Xia, Yi ; Wu, Wei ; Cao, Lei ; Fan, Lei ; Li, Jian-Yong ; Xu, Wei

作者单位： Jiangsu Univ, Affiliated Peoples Hosp, Dept Hematol, Zhenjiang, Jiangsu, Peoples R China ^[1] Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R ^[2] Air Force Hosp Eastern Theater Command, Dept Hematol, Nanjing, Jiangsu, Peoples R China ^[3]

发布时间 2020-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Haematologica

2020年105卷1期

E29-E32页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial

Haematologica

相似文献

Haematologica

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial

Haematologica

相似文献

Haematologica

相关期刊

检索历史清除